Randomized Phase II Study of Everolimus (E) Versus Everolimus plus Bevacizumab (E plus B) in Patients (Pts) With Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors (pNET), CALGB 80701 (Alliance)

Journal Article (Journal)

Full Text

Link to Item

Duke Authors

Niedzwiecki, Donna

Cited Authors

Kulke, MH; Niedzwiecki, D; Foster, NR; Fruth, B; Kunz, PL; Kennecke, H; Wolin, EM; Venook, AP

Published Date

March 1, 2016

Published In

Pancreas

Volume / Issue

45 / 3

Start / End Page

477 - 477

Published By

LIPPINCOTT WILLIAMS & WILKINS

Pages

1

Electronic International Standard Serial Number (EISSN)

1536-4828

International Standard Serial Number (ISSN)

0885-3177

Language

English